These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12640209)

  • 1. Is treatment failure for hepatitis C virus infection in HIV-positive drug users associated with a shift in HCV genotypes?
    Soriano V; Pérez-Olmeda M; Ríos P; Núñez M; García-Samaniego J; González-Lahoz J
    J Acquir Immune Defic Syndr; 2003 Apr; 32(4):465-6. PubMed ID: 12640209
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype.
    Soriano V; Ramos B; Nunez M; Barreiro P; Maida I; Garcia-Samaniego J; Gonzalez-Lahoz J
    J Infect Dis; 2005 Oct; 192(7):1245-8. PubMed ID: 16136468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients.
    Medrano J; Resino S; Vispo E; Madejón A; Labarga P; Tuma P; Martín-Carbonero L; Barreiro P; Rodriguez-Novoa S; Jiménez-Nacher I; Soriano V
    J Viral Hepat; 2011 May; 18(5):325-30. PubMed ID: 20456635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of hepatitis C virus core region in moroccan intravenous drug users.
    Trimbitas RD; Fayssel N; Serghini FZ; Wakrim L; Khyatti M; Essalhi M; Bellefquih AM; Benani A
    J Med Virol; 2016 Aug; 88(8):1376-83. PubMed ID: 26754854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV genotype 5: epidemiology and spread of an uncommon genotype.
    Verbeeck J; Peigue-Lafeuille H; Ross RS; Abergel A; Nevens F; Van der Merwe S; Van Ranst M; Henquell C
    J Clin Virol; 2008 Feb; 41(2):170-1. PubMed ID: 18069057
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of hepatitis C virus genotype 4.
    Abdo AA; Lee SS
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1233-9. PubMed ID: 15482528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hepatitis C.
    Satoor S; Raufman JP
    Clin Cornerstone; 2001; 3(6):37-46. PubMed ID: 11501193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV and HCV co-infection: situation at six French university hospitals in the year 2000.
    Buffet-Janvresse C; Peigue-Lafeuille H; Benichou J; Vabret A; Branger M; Trimoulet P; Goria O; Laurichesse H; Abbed A; Verdon R; Bouvet E; Lafon ME; Dussaix E; Cormerais L; Dupon M; Henquell C; Josse A; Lagoutte P; Lariven S; LeGac S; Riachi G; Verdon R; Vittecoq D;
    J Med Virol; 2003 Jan; 69(1):7-17. PubMed ID: 12436472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
    Lucidarme D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
    [No Abstract]   [Full Text] [Related]  

  • 12. High uptake of hepatitis C virus treatment in HIV/hepatitis C virus co-infected patients attending an integrated HIV/hepatitis C virus clinic.
    Kieran J; Dillon A; Farrell G; Jackson A; Norris S; Mulcahy F; Bergin C
    Int J STD AIDS; 2011 Oct; 22(10):571-6. PubMed ID: 21998177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin.
    Gilleece YC; Browne RE; Asboe D; Atkins M; Mandalia S; Bower M; Gazzard BG; Nelson MR
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):41-6. PubMed ID: 16123680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatitis C: a decision that needs careful consideration.
    Wright TL
    Am J Med; 1999 Aug; 107(2):180-1. PubMed ID: 10460052
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of hepatitis C.
    Sievert W; Batey RG
    Med J Aust; 1999 Mar; 170(5):200-2. PubMed ID: 10092915
    [No Abstract]   [Full Text] [Related]  

  • 16. Management issues in patients coinfected with hepatitis C virus and HIV.
    Bonacini M
    AIDS Read; 2002 Jan; 12(1):19-21, 24-6. PubMed ID: 11862656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral kinetics and early prediction of nonresponse to peg-IFN-alpha-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus.
    Moreno A; Bárcena R; García-Garzón S; Moreno L; Quereda C; Muriel A; Zamora J; Mateos ML; Pérez-Elías MJ; Antela A; Diz S; Moreno A; Moreno S
    J Viral Hepat; 2006 Jul; 13(7):466-73. PubMed ID: 16792540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection fighters. Hepatitis C--is a cure possible?
    TreatmentUpdate; 2005; 17(1):8-9. PubMed ID: 17225319
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis C virus infection--after 20 years].
    Pár A
    Orv Hetil; 2010 Mar; 151(12):485-93. PubMed ID: 20231132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol].
    Pivert A; Payan C; Lunel F;
    Pathol Biol (Paris); 2004 Nov; 52(9):522-8. PubMed ID: 15531116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.